Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologic analysis in cases with and without progestogen treatment

International Journal of Gynecological Cancer

Volumn 14, Issue 2, 2004, Pages 348-353

  Horn, Lars Christian ^a   Schnurrbusch, U ^a   Bilek, K ^a   Hentschel, B ^a   Einenkel, J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Hormonal treatment; Interobserver correlation; Progression

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; CANCER GROWTH; CANCER REGRESSION; DISEASE COURSE; DRUG USE; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; VAGINA BLEEDING;

ADENOCARCINOMA; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; NORETHINDRONE; PROGESTINS;

EID: 2042465026     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.014220.x     Document Type: Article

References (32)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J Clin 2003; 53:5-26.
2. Hoffman K, Nekhlyudar L, Delogclish L. Endometrial carcinoma in elderly women. Gynecol Oncol 1995; 58:198-201.
3. Burton JL, Wells M. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathologg 1998;33:297-303.
4. Sherman ME, Kurman RJ. Evolving concepts in endometrial carcinogenesis. Importance of DNA repair and deregulated growth. Hum Pathol 1998;29:1035-8.
5. Baak JPA, Wisse-Brekelmans ECM, Fleege JC, van der Putten HWHM, Bezemer PD. Assessment of the risk on endometrial cancer in hyperplasia by means of morphological and morphometrical features. Path Res Pract 1992;188:856-9.
6. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985;56:403-12.
7. Pérez-Medina T, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: Long-term follow up. Gynecol Oncol 1999;73:299-304.
8. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547-59.
9. Longacre TA, Chung MH, Jensen DN, Hendrickson MR. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 1995;19:371-406.
10. Bergeron C, Nogales FF, Masseroli M et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified Working Classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-8.
11. Kendall BS, Ronnet BM, Isacson C et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia and well-differentiated carcinoma. Am J Surg Pathol 1998;22:1012-9.
12. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. WHO - Histological typing of female genital tract tumours. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer, 1994.
13. Seidell JC. Obesity in Europe. Scaling Epidemic Int J Relat Metab Disord 1995;19:S1-S4.
14. Horn LC, Riethdorf L, Löning T. Guidelines for preparing surgically uterine specimens. Pathologe 1999;20:9-14.
15. Horn LC, Lax SF, Höckel M, Fischer U, Schmidt D. Precancerous lesions of the endometrium: a review of the molecular pathogenesis and problems in terminology. Geburtsh Frauenheilk 2001;61:8-14.
16. Dallenbach-Hellweg G, Schmidt D. Oestrogens and proliferation of endometrial cells. J Cardiol Pharmacol 1996;28:24-8.
17. Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989;160:126-31.
18. Huang SJ, Amparao EG, Fu YS. Endometrial hyperplasia. Histologic classification and behavior. Surg Pathol 1988;1:215-29.
19. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997;90:434-40.
20. Wentz WB. Treatment of persistent endometrial hyperplasia with progestins. Am J Obstet Gynecol 1966;96:999-1004.
21. Janicek MF, Rosensheim NB. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecol Oncol 1994;52:373-8.
22. Tavassoli FA, Kraus FT. Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 1978;70:770-9.
23. Widra EA, Dunton CJ, McHigh M, Palazzo JP. Endometrial hyperplasia and the risk of carcinoma. Int J Gynaecol Cancer 1995;5:233-5.
24. Mecke H, Lüttges J, Lehmann-Willenbrook E, Kunstmann P, Freys I. Treatment of precursors of endometrial cancer. Gynecol Obstet Invest 1994;37:130-4.
25. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestine alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997;79:320-7.
26. Kaku T, Tsukamoto N, Hachisuga T et al. Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 1996;60:22-5.
27. Skov BG, Broholm H, Engel U et al. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol 1997;16:33-7.
28. Bergeron C, Nogales FF, Masseroli M et al. Endometrioid neoplasia retrogressive terminology (authors reply). Am J Surg Pathol 2000;24:754-5.
29. Prat J. Histologic diagnosis of endometrial hyperplasia. Virch Arch 2002;441:306-7.
30. Scully RE, Young RH. Endometrioid neoplasia retrogressive terminology (Letter Editor). Am J Surg Pathol 2000;24:753-4.
31. Mutter GL and the Endometrial Collaborative Group. Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos? Gynecol Oncol 2000;76:287-90.
32. Kiechle M, Hinrichs M, Jacobsen A et al. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization. Am J Pathol 2000;156:1827-33.